Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.
Tonight has seen ADFEST 2026 award the first of two presentations of Lotus Awards to the elected winners in 12 categories, including Brand Experience, Commerce, Digital & Social, Direct, Digital Craft ...
Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...
Google, Walmart, Mastercard and other companies want you to use agentic AI for financial transactions. Here's when this makes sense and when to steer clear. Financial planner Stephen Kates thinks ...
ASX healthcare stocks remain under pressure, but strong clinical and regulatory catalysts are still driving standout gains ...
Detailed price information for Antelope Enterprise Hldg Ltd (AEHL-Q) from The Globe and Mail including charting and trades.
It’s that time again! MLB Opening Day is a week away, so it’s time to update the rankings one last time. This is now my third ...
PICKERINGTON, OH, UNITED STATES, March 20, 2026 /EINPresswire.com/ -- Empowering Teams, Developing Talent, and ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...
Annual awards program recognizes the company’s excellence in cybersecurity innovation, measurable mission impact, and ...
Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results